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Nosocomial infections due to bacteria have serious implications on the health and recovery of patients in a
variety of medical scenarios. Since bacterial contamination on medical devices contributes to the majority
of nosocomical infections, there is a need for redesigning the surfaces of medical devices, such as catheters
and tracheal tubes, to resist the binding of bacteria. In this work, polyurethanes and polyacrylates/
acrylamides, which resist binding by the major bacterial pathogens underpinning implant-associated
infections, were identiﬁed using high-throughput polymer microarrays. Subsequently, two ‘hit’ polymers,
PA13 (poly(methylmethacrylate-co-dimethylacrylamide)) and PA515 (poly(methoxyethylmethacrylate-co-
diethylaminoethylacrylate-co-methylmethacrylate)), were used to coat catheters and substantially shown
to decrease binding of a variety of bacteria (including isolates from infected endotracheal tubes and
heart valves from intensive care unit patients). Catheters coated with polymer PA13 showed up to 96%
reduction in bacteria binding in comparison to uncoated catheters.Introduction
Nosocomial or hospital related infections, i.e., infection
acquired by a patient who was initially admitted for a reason
other than infection, are widespread in patients in intensive
care units and those requiring long-term catheter use. It has
been estimated that in the US 1.7 million patients acquire a
nosocomial infection each year, resulting in over 90 000
deaths.1 In the UK, one in ten patients acquire a nosocomial
infection costing the economy >£1 billion per year.2 These
infections pose major issues for patient care, which are further
complicated by the emergence of global antibiotic resistant
organisms.ity of Edinburgh, King's Buildings, West
ail: mark.bradley@ed.ac.uk; Tel: +44 (0)
Edinburgh, King's Buildings, West Mains
gallagher@ed.ac.uk; Tel: +44 (0)131 650
y of Edinburgh, 51 Little France Crescent,
(ESI) available: Polymer microarray
adhesion by uorescence microscopy
acteria repelling polymers identied in
racterisation; preparation of catheter
or confocal imaging/analysis. See DOI:
hemistry 2014Bacteria account for the majority of nosocomial infections3
and adhesion of bacteria to a surface, such as a catheter, is an
essential step in the process.4 Moreover, bacteria on a surface
provide a source for reseeding infection, once established in a
biolm.5 Initial bacterial adhesion is aﬀected by the relative
charge and hydrophobicity of the surface, and by chemical
interactions between the bacteria and the surface and/or
secreted components and/or components of biological uids on
the surface.6–8 Attachment is followed by production of extra-
cellular polysaccharides and proteins by the bacteria, as the
biolm establishes.7 The biolm provides a physical barrier
against both the host immune system and antimicrobial
therapy, and bacteria within biolms can have >1000-fold
higher resistance to some antibiotics as compared to planktonic
bacteria.9 As biolms are involved in the majority of microbial
infections, including chronic infections, prevention of biolm
formation is important in a clinical setting.10
Since medical devices oen contribute to nosocomial infec-
tions,11 there is an interest to render the surface of these devices
resistant to bacterial adhesion and biolm formation.12 As such,
the surface of a medical device can be craed to contain agents,
including antibiotics or bactericides (e.g. silver, iodine or
surfactants).13–17 These modied surfaces prevent colonisation
by killing bacteria on contact or by the release of antimicrobials
in the area surrounding the medical device. When suboptimal,
this approach is not ideal since it can contribute to the emer-
gence of resistant strains.14 In addition, some of the agents used
on the craed surfaces are expensive and may not be suitableJ. Mater. Chem. B, 2014, 2, 6723–6729 | 6723
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View Article Onlinefor use with all patients as they may elicit allergic reactions.7 A
more attractive alternative to prevent bacterial adhesion would
be to coat the medical device with a polymer, which inherently
resists adhesion of bacteria.18
The traditional approaches for the discovery of polymer-
based biomaterials with new properties are time-consuming
and iterative, involving sequential study of individual polymer
for the desired properties, followed by their structural optimi-
sation. As an alternative approach, well-plate based screening
methods have been used to identify bacteria-repelling
surfaces.19,20 For example, a well-plate based assay allowed the
comparison of adhesion of Staphylococcus aureus (S. aureus) on
synthetic and biologically derived surgical materials used in
plastic surgery.21 However, well-plate based methods are typi-
cally limited to relatively small number of surfaces to be
assessed in parallel. To enable a high-throughput approach to
the discovery of new biomaterials, Bradley22 and Langer23 have
developed polymer microarray platforms. These have resulted
in the identication of biomaterials by Bradley for various
applications such as for the long-term culture of mouse
embryonic stem cells,24 culture of human embryonic stem cells
and mesenchymal stem cells with thermal harvesting,25,26 and
the activation of platelets.27 In addition, polymer microarrays
have been used to identify materials able to capture or prevent
the binding of Escherichia coli, the major food-borne pathogen
Salmonella enterica serovar Typhimurium,28 Pseudomonas aeru-
ginosa, Escherichia coli and S. aureus,29 and the protozoan
parasites Giardia lamblia30 and Cryptosporidium parvum.31
The aim of this study was to utilise polymer microarrays to
identify polymers with anti-adhesive characteristics against a
range of clinically important Gram-negative and Gram-positive
bacteria. Thus, a library of 381 polyacrylates/acrylamides and
polyurethanes was screened for their ability to reduce/prevent
attachment of a range of major bacterial pathogens including
Campylobacter jejuni (C. jejuni), Clostridium diﬃcile (C. diﬃcile),
Clostridium perfringens (C. perfringens), Streptococcus mutans
(S. mutans), Klebsiella pneumoniae (K. pneumoniae), Staphylococcus
saprophyticus (S. saprophyticus), Enterococcus faecalis (E. faecalis)
and S. aureus either individually or in microbial ‘cocktails’. Key
bacteria repellent ‘hit’ polymers, identied using the micro-
array screens, were scaled-up and their ability to resist bacterial
attachment was conrmed on larger surfaces. Two polymers
were chosen for detailed study and used to coat two types of
commercially available intravenous catheters. Confocal
microscopy and scanning electron microscopy (SEM) analysis
were used to study and quantify bacteria binding on the coated
and uncoated catheters.
Materials and methods
All chemicals were of analytical grade and used without further
purication. Sodium cacodylate trihydrate, formaldehyde,
monomers for polymer synthesis, and silane-prep glass slides
were purchased from Sigma-Aldrich. Glutaraldehyde (2.5% w/v)
and osmium tetroxide (1% w/v) were from Electron Microscopy
Sciences. Well plates were purchased from Nunc, glass cover-
slips from VWR, and GeneFrames from Thermo Scientic.6724 | J. Mater. Chem. B, 2014, 2, 6723–6729Polyurethane large bore multi-lumen central intravenous cath-
eterisation sets (Cath-1) were purchased from Arrow Interna-
tional (CS12123E), and silicone double lumen catheter sets with
stylet (Cath-2) from Baxter Healthcare Corporation (ECS1320).
Polymer synthesis and characterisation
For coating of the catheters, PA13 (Mw 411 kDa, PDI 3.4), PA515
(Mw 90 kDa, PDI 2.7) and PA155 (Mw 9.5 kDa, PDI 1.2) were
synthesised by free-radical polymerisation and characterised by
gel permeation chromatography (GPC) and infrared spectros-
copy (IR) (see ESI†). GPC was conducted on an Agilent GPC
instrument, tted with a PLgel 5 mm MIXED-C column (300 
7.5 mm), with NMP as eluent (ow rate 1 mL min1), pre-cali-
brated using polystyrene standards. IR analysis was conducted
using a Brucker Tensor 27 spectrometer.
Coating of the catheters
Depending on the concentration/viscosity of the polymer solu-
tions, two methods of coating were employed, with polymer
loading conrmed by increase in weight of the catheter pieces
aer coating and drying (ESI†). For the binding studies by
confocal microscopy, 2.5% polymer solutions in acetone (w/v)
were used. The catheter pieces were placed into a small glass
vial (5 mL) and 1 mL of the polymer solution was added for 2
min. The excess polymer solution was removed and the catheter
pieces were dried overnight in vacuo at 40 C. For the SEM
studies, catheter coating was achieved by immersing the pieces
into 10% PA13 solution in acetone (w/v) for 30 seconds. The
coated pieces were air dried for 30 min and then re-coated by
immersing into the polymer solution. The pieces were dried
overnight at room temperature.
Preparation of bacteria and seeding on catheters
K. pneumoniae, S. saprophyticus, S. aureus, E. faecalis, and
S. mutans were cultured on agar-coated Petri dishes with brain–
heart–infusion (BHI) medium in a microaerobic environment
(85% N2, 10% CO2, 5% O2) at 37 C. For S. mutans strain NCTC
10923 was used. All other strains were clinical isolates obtained
from infected medical devices and identied by PCR genotyp-
ing. Frozen stock of the bacteria was prepared and used for all
experiments, to enable seeding known count of bacteria and
ensuring consistency between experiments. For preparing the
frozen stocks, overnight cultures of each strain were set up:
bacteria were inoculated into 50 mL of BHI and incubated in a
Falcon tube in a microaerobic environment at 37 C for 12 h,
except for S. mutans, which was incubated for 36 h. Cultures
were frozen aer addition of 10% glycerol, and the number of
colony forming units (CFU) per mL in the frozen stock deter-
mined through serial dilution.
For the catheter experiments, BacMix-1 and BacMix-2 were
prepared from frozen stocks. BacMix-1 was prepared with
K. pneumoniae, S. saprophyticus, and S. aureus, approximately
5 105 CFU of each bacteria in 50 mL of BHImedium. BacMix-2
was prepared with K. pneumoniae, S. mutans, S. aureus, and
E. faecalis, with all the strains other than S. mutans maintained
at 5  105 CFU per 50 mL of BHI medium. Due to its lowerThis journal is © The Royal Society of Chemistry 2014
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View Article Onlineproliferation rate, S. mutans was seeded in approximately 2-fold
higher density.
For studies via confocal microscopy, pieces (n ¼ 3) of
uncoated catheters Cath-1 and Cath-2, those coated with poly-
mers PA13, PA515 or control PA155 were placed in agarose
coated 24-well plates, sterilised by UV (20 min), and inoculated
with 1 mL of either BacMix-1 or BacMix-2. Aer seeding, the
plates were incubated for 72 h in amicroaerobic environment at
37 C, with agitation at 50 rpm. The media was supplemented
with 0.5 mL of BHI at 24 h and 48 h. For quantication of
bacterial binding using SEM, catheters were seeded with 2 mL
of bacterial stocks and incubated in medium for 12 days with
agitation at 50 rpm.Quantication of bacteria binding
Confocal microscopy analysis. Catheter samples (n¼ 3) were
washed with PBS (2  2 mL) aer incubation with bacteria. The
cells were xed with 10% paraformaldehyde in PBS for 30 min,
and washed with PBS (1 mL). The bacteria on catheter pieces
were stained with DAPI (1 mg mL1) for 20 min and washed
again with PBS (1 mL). Confocal imaging was performed on a
Leica SP5 confocal microscope using lex 405 nm and 414–502
nm emission lter, and images analysed using Image-pro plus
7.0, to obtain percentage of area of bacterial coverage (ESI†).
SEM analysis. SEM imaging was conducted using a Philips
XL30 CP electron microscope. Aer incubation with bacteria,
the pieces (n¼ 3) were washed with PBS (2 1 mL) before being
transferred into 48-well plates containing 10% formaldehyde in
PBS for 30 min. Aer xing, the pieces were washed with PBS
(1 mL). The catheters were then loaded on stubs, dried over-
night at room temperature, and gold coated using a Bal-Tec
SCD050 sputter coater prior to imaging.Table 1 ‘Hit’ polymers used in scaled-up studies
Polymer Description
PA13 Co-polymer of methylmethacrylate and dimethylacrylamide
(9 : 1 monomer ratio)a
PA515 Co-polymer of methoxyethylmethacrylate,
diethylaminoethylacrylate and methylmethacrylate (6 : 1 : 3
monomer ratio)
PA338 N-Methylaniline functionalised co-polymer of
methylmethacrylate and glycidylmethacrylate (1 : 1 monomer
ratio)
PU5 Polyurethane synthesised from poly(butyleneglycol)2000 and
1,6-diisocyanatohexane (1 : 1 monomer ratio)
PU20 Polyurethane synthesised from poly(butyleneglycol)2000 and
4,40-methylenebis(phenylisocyanate) (1 : 1 monomer ratio)
PU83 Polyurethane synthesised from poly(ethyleneglycol)900 and
4,40-methylenebis(cyclohexylisocyanate), with 1,4-butanediol
as a chain extender (1 : 2 : 1 monomer ratio)
PU179 Polyurethane synthesised from poly(butyleneglycol)2000 and
1,6-diisocyanatohexane, with 2-nitro-2-methyl-1,3-propanediol
as a chain extender (1 : 2 : 1 monomer ratio)
a Refers to the monomer ratio used in the synthesis of the polymer.Results and discussion
High-throughput identication of bacteria repelling polymers
Polymer microarrays with 381 polymer members (each printed
in quadruplicate) were fabricated by contact printing of pre-
formed polymers as described previously.22 Individual cultures
(C. jejuni, C. diﬃcile, C. perfringens, and S. mutans) and two
clinically relevant bacteria mixtures, BacMix-1 (consisting of
K. pneumoniae, S. saprophyticus and S. aureus) and BacMix-2
(consisting of K. pneumoniae, S. mutans, S. aureus, and E. fae-
calis), were incubated overnight on the arrays. The strains in
BacMix-1 and BacMix-2 were obtained from endotracheal tubes
from ICU patients or from patients exhibiting infectious endo-
carditis, oen associated with cardiovascular implants. Aer
washing and staining, bacterial adhesion on each of the poly-
mer features was evaluated via nucleoid staining, allowing
polymer ranking (ESI, Table S1†). Detailed analysis of the arrays
showed diﬀerences in the bacterial repellence of specic poly-
mers for diﬀerent strains, with 11 polyacrylates/acrylamides
and 11 polyurethanes showing strong repellence for C. jejuni,
C. diﬃcile, C. perfringens, and S. mutans, as well as the mixtures
BacMix-1 and BacMix-2 (ESI, Fig. S1–S8†).This journal is © The Royal Society of Chemistry 2014Analysis of the chemical composition of the ‘hit’ poly-
acrylates/acrylamides revealed some common structural char-
acteristics, with 10 out of the 11 hits containing tertiary amino
groups, with aliphatic amines (7 out of the 10) rendering the
surface positively charged in biological media. Interestingly,
one of the most repellent co-polymers PA13 (poly-
(methylmethacrylate-co-dimethylacrylamide)) did not contain
amines but contained amide functionalities, neutral at
physiological pH. The majority of the best non-binding
polyurethanes lacked charged functionalities and were
found to contain either poly(butyleneglycol)2000 or poly-
(ethyleneglycol)900/2000 (ESI, Table S2 and S3†), consistent with
the fact that polyglycol groups are known to contribute to
resistance to bacterial attachment.32,33Whether the ability of the
polymer surface to resist adhesion of bacteria can be predicted
from chemical composition of the polymer is an interesting
question. Adhesion of bacteria to polymeric surfaces is a result
of complex interplay between characteristics of the bacteria,
physicochemical properties of the polymer surface and nature
of the medium in which the bacteria and the surface interact. In
addition, roughness and morphology of the surface aﬀect the
adhesion.34 Although there is some vague similarity between the
resistant polymers, correlating bacteria resistance to chemical
composition of the polymers is problematic,35 further high-
lighting the advantages of the high-throughput discovery
process, which is designed to give leads for further
optimisation.
To validate the ‘hits’ and to further explore the bacteria-
repellent activity of the polymers on a larger scale, the most
promising polyacrylates/acrylamides PA13, PA515, and PA338
and polyurethanes PU5, PU20, PU83 and PU179 (see Table 1)
were spin-coated onto glass coverslips and assessed for binding
by BacMix-1 and BacMix-2. Scanning Electron Microscopy
(SEM) was used to quantify the number of bacteria attached toJ. Mater. Chem. B, 2014, 2, 6723–6729 | 6725
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View Article Onlineeach polymer surface (ESI, Fig. S9 and S10†). Polyacrylates PA13
and PA515 and polyurethane PU83 were found to exhibit the
lowest bacteria binding (Fig. 1A and B).
In general, polyacrylates/acrylamides oﬀer a exible coating
material since they can be used either as a solution of pre-
formed polymers or synthesised in situ on surfaces using a
range of polymerisation techniques. Therefore, PA13 and PA515
(methoxyethylmethacrylate-co-diethylaminoethylacrylate-co-
methylmethacrylate) were chosen to coat two commercially
available types of catheter to study whether the polymers render
the surface resistant to bacterial adhesion. Another polyacrylate
PA155 (poly(hydroxyethylmethacrylate-co-dimethylaminoe-
thylmethacrylate)), identied in a previous study to oﬀer good
bacterial binding,28 was chosen as a control (Fig. 1C). Due to
their clinical relevance, BacMix-1 and BacMix-2 were used for
binding studies on the coated catheters.Coating of catheters
A polyurethane-based multi-lumen central intravenous catheter
(Cath-1) and a silicone-based double lumen catheter (Cath-2)
were coated and evaluated. The catheters were cut into cylin-
drical pieces (and the dimensions of the catheter analysed,
ESI†) and coated with PA13, PA515, and the control PA155. A
range of solvents was evaluated both for their ability to dissolveFig. 1 (A) SEM images of glass and selected polymer surfaces after incu
bacteria per mm2 on the polymers, agarose and glass (n ¼ 4) after incu
PA515 and PA155. The ratio of monomers used in the synthesis is given
6726 | J. Mater. Chem. B, 2014, 2, 6723–6729the polymers and for compatibility with the catheters. Thus,
pieces of catheters were immersed in solvents for 12 h and
evaluated for any visual changes (e.g. cloudiness or swelling,
ESI, Fig. S12†). Both catheter materials tolerated acetone, which
due to its low boiling point and fast evaporation, is an ideal
solvent to achieve uniform coating. Polymers PA13, PA515 and
PA155 were fully soluble in acetone. Polymer loading on the
surfaces was established by treating both Cath-1 and Cath-2
with 10% (w/v) PA13. Cath-1–PA13 showed an average weight
increase of 36% and Cath-2–PA13 an average increase of 11%,
suggesting that better coating was achieved on Cath-1.
Uncoated pieces of Cath-1 and Cath-2, and those coated with
polymers PA13, PA515 and PA155 in acetone, were inoculated
with either BacMix-1 or BacMix-2. Aer incubation, the cathe-
ters were washed, and the bacteria xed and stained with DAPI.
Confocal images of the catheter pieces showed signicantly
improved resistance to bacterial binding on the PA13 and PA515
coated catheters, compared to the uncoated catheters (Fig. 2A),
whereas coating with control PA155 resulted in high bacterial
binding (data not shown).
Analysis of the confocal images showed that PA13 had better
repellent characteristics than PA515 (Fig. 2B and C). Reduction
in bacterial binding with the polymer coatings varied with the
catheter type and bacterial mixture used. For Cath-1, coating
with PA515 resulted in 64% reduction in bacterial coverage withbation with bacteria (scale bar ¼ 20 mm). (B) The average number of
bation with bacteria. (C) Structures of the random co-polymers PA13,
in the brackets.
This journal is © The Royal Society of Chemistry 2014
Fig. 2 (A) Confocal ﬂuorescence images ( 40magniﬁcation, lex 405 nm, lem 414–502 nm) of catheter surfaces showing bacteria binding/non-
binding. The images were obtained after 72 h incubation with bacteria, followed by washing, ﬁxing and staining with DAPI (1 mg mL1). (a and b)
uncoated Cath-1, (c and d) uncoated Cath-2, (e and f) Cath-1–PA13, (g and h) Cath-2–PA13, (i and j) Cath-1–PA515, (k and l) Cath-2–PA515. (B)
The percentage of surface area covered by bacteria after 72 h incubation with BacMix-1 and BacMix-2, and (C) percentage of reduction in
bacteria binding, obtained by comparing the area of bacteria coverage to the area of the image (n ¼ 3, see ESI†).
Fig. 3 SEM images of uncoated and coated catheters after incubation with BacMix-1 and BacMix-2 (scale bar ¼ 10 mm). (a and b) Cath-1, (c and
d) Cath-1–PA13, (e and f) Cath-2, (g and h) Cath-2–PA13. See ESI† for additional images of Cath-1–PA13 with BacMix-1 (Fig. S14†).
This journal is © The Royal Society of Chemistry 2014 J. Mater. Chem. B, 2014, 2, 6723–6729 | 6727
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View Article OnlineBacMix-2, while coating with PA13 oﬀered $96% reduction in
coverage for both bacterial mixtures. Similarly for Cath-2,
coating with PA515 resulted in a moderate 19% reduction in
bacterial coverage with BacMix-1, while PA13 coating yielded
$82% reduction with both BacMix-1 and BacMix-2, therefore
making PA13 the coating polymer of choice.
SEM analysis was performed to study the reduction of
bacterial adhesion on Cath-1–PA13 and Cath-2–PA13. Coated
(10% w/v PA13 in acetone) and uncoated catheter pieces were
incubated with BacMix-1 and BacMix-2 for 12 days, to mimic the
duration of use in a clinical environment. The catheter pieces
were then washed, gold coated and imaged. SEM analysis
showed that coating with PA13 signicantly reduced bacteria
binding on the surface of both catheter types (Fig. 3). Also, the
surfaces of the coated catheters looked smooth and consider-
ably diﬀerent from the uncoated catheter surfaces, conrming
uniform coating with PA13. The thickness of the polymer
coating was measured by cutting the coated catheters and
imaging by SEM (ESI, Fig. S13†). Coating with PA13 resulted in a
92 mm and 54 mm layer on Cath-1 and Cath-2, respectively.Conclusions
A 381-member polymer library was screened on polymer
microarrays with bacterial strains (C. jejuni, C. diﬃcile, C. per-
fringens, and S. mutans) and two clinically relevant bacteria
mixtures, BacMix-1 (consisting of K. pneumoniae, S. saprophyti-
cus and S. aureus) and BacMix-2 (consisting of K. pneumoniae, S.
mutans, S. aureus, and E. faecalis). This high-throughput screen
identied polyacrylate/acrylamide and polyurethane-based
substrates that prevented the adhesion of both Gram-negative
and Gram-positive bacteria. Scale-up studies with the two clin-
ically relevant bacterial mixtures revealed that polyurethane
PU83 and polyacrylates/acrylamides PA13 and PA515 exhibited
broad-spectrum bacteria repellence, suggesting potential for
use as coatings for medical devices. PA13 and PA515 were used
to uniformly coat both a polyurethane-based and a silicone-
based intravenous catheteter. Coating with PA13 was found to
signicantly reduce bacterial binding when compared to
uncoated catheters as analysed by confocal microscopy and
SEM. This study shows that polymers such as PA13, identied
through a high-throughput screening approach, have potential
as antibiotic-free bacteria-repellent coatings for medical
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